Primary Central Nervous System Lymphoma
GPTKB entity
Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:cancer
gptkb:disease |
| gptkbp:affects |
central nervous system
|
| gptkbp:alsoKnownAs |
PCNSL
primary cerebral lymphoma |
| gptkbp:diagnosedBy |
MRI
biopsy CSF analysis |
| gptkbp:firstDescribed |
1929
|
| https://www.w3.org/2000/01/rdf-schema#label |
Primary Central Nervous System Lymphoma
|
| gptkbp:ICD-10_code |
C83.3
|
| gptkbp:location |
gptkb:spinal_cord
brain eyes leptomeninges |
| gptkbp:medianSurvival |
2-5 years
|
| gptkbp:mostCommonCellType |
diffuse large B-cell lymphoma
|
| gptkbp:prognosis |
poor
|
| gptkbp:riskFactor |
organ transplantation
immunosuppression HIV infection |
| gptkbp:subspecies |
leukemia
extranodal lymphoma |
| gptkbp:symptom |
headache
cognitive impairment seizures focal neurological deficits |
| gptkbp:treatment |
radiation therapy
chemotherapy corticosteroids high-dose methotrexate |
| gptkbp:bfsParent |
gptkb:PCNS
|
| gptkbp:bfsLayer |
6
|